OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers in Post-kala-azar Dermal Leishmaniasis
Eduard E. Zijlstra
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Leishmaniasis cutánea y mucocutánea
Isabel Abadías‐Granado, A. Diago, P.A. Cerro, et al.
Actas Dermo-Sifiliográficas (2021) Vol. 112, Iss. 7, pp. 601-618
Open Access | Times Cited: 70

Advancement in leishmaniasis diagnosis and therapeutics: An update
Diksha Kumari, Summaya Perveen, Rashmi Sharma, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174436-174436
Closed Access | Times Cited: 60

Cutaneous and Mucocutaneous Leishmaniasis
Isabel Abadías‐Granado, A. Diago, P.A. Cerro, et al.
Actas Dermo-Sifiliográficas (2021)
Open Access | Times Cited: 58

Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs
Paul M. Kaye, Israel Cruz, Albert Picado, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 3, pp. 247-264
Open Access | Times Cited: 66

Post kala-azar dermal leishmaniasis: A threat to elimination program
Mallikarjuna Rao Gedda, Bhawana Singh, Dhiraj Kumar, et al.
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 7, pp. e0008221-e0008221
Open Access | Times Cited: 53

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Brima M. Younis, Mohamed Osman, Eltahir Awad Gasim Khalil, et al.
Molecular Therapy (2021) Vol. 29, Iss. 7, pp. 2366-2377
Open Access | Times Cited: 50

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Hayelom Berhe Dagnaw, Mahesh Kumar Cinthakunta Sridhar, Mulate Zerihun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 227-227
Open Access | Times Cited: 5

New Strategies and Biomarkers for the Control of Visceral Leishmaniasis
Ana Victoria Ibarra‐Meneses, Javier Moreno, Eugenia Carrillo
Trends in Parasitology (2019) Vol. 36, Iss. 1, pp. 29-38
Closed Access | Times Cited: 35

Development of Novel Anti-Leishmanials: The Case for Structure-Based Approaches
Mohini Soni, J. Venkatesh Pratap
Pathogens (2022) Vol. 11, Iss. 8, pp. 950-950
Open Access | Times Cited: 20

Ocular Leishmaniasis - A systematic review
Guillaume Mignot, Yagnaseni Bhattacharya, Aravind Reddy
Indian Journal of Ophthalmology (2021) Vol. 69, Iss. 5, pp. 1052-1060
Open Access | Times Cited: 21

Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis
Shumaila Naz, Aiman Aroosh, Ayşe Caner, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 339-339
Open Access | Times Cited: 8

DNA-based microarray studies in visceral leishmaniasis: identification of biomarkers for diagnostic, prognostic and drug target for treatment
Awanish Kumar, Satish Chandra Pandey, Mukesh Samant
Acta Tropica (2020) Vol. 208, pp. 105512-105512
Closed Access | Times Cited: 23

Vaccine efficacy induced by virus-like particles containing Leishmania donovani surface glycoprotein GP63
Keon-Woong Yoon, Ki‐Back Chu, Gi-Deok Eom, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 6, pp. e0012229-e0012229
Open Access | Times Cited: 2

Molecular Tracking of the Leishmania Parasite
Srija Moulik, Shilpa Sengupta, Mitali Chatterjee
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 14

Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasis
Prakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9

A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings
Prakash Ghosh, Abhijit Sharma, Narayan Raj Bhattarai, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 588-588
Open Access | Times Cited: 12

Development and Clinical Evaluation of Serum and Urine-Based Lateral Flow Tests for Diagnosis of Human Visceral Leishmaniasis
Sarfaraz Ahmad Ejazi, Somsubhra Thakur Choudhury, Anirban Bhattacharyya, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 8

An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics
Florentina Daraban Bocaneti, Larisa IVĂNESCU, Liviu Miron, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 11, pp. 334-334
Open Access | Times Cited: 5

Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis
Srija Moulik, Ritika Sengupta, Manab Ghosh, et al.
Indian Journal of Dermatology Venereology and Leprology (2021) Vol. 88, pp. 201-206
Open Access | Times Cited: 6

Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients
Nibedeeta Rani Sarraf, Saikat Mukhopadhyay, Anindyajit Banerjee, et al.
Acta Tropica (2021) Vol. 223, pp. 106086-106086
Open Access | Times Cited: 6

Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Eduard E. Zijlstra
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 6

Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan
Ambika Rani Pradhan, Tashi Tobgay, Sithar Dorjee, et al.
Case Reports in Dermatological Medicine (2020) Vol. 2020, pp. 1-4
Open Access | Times Cited: 4

Pathophysiology of Leishmaniasis
Ghazi Salih, Ajwad Assumaidaee
Egyptian Journal of Veterinary Science (2024) Vol. 56, Iss. 1, pp. 195-203
Open Access

The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
Nir Qvit, Mulate Zerihun, Mahesh Kumar, et al.
(2023)
Open Access | Times Cited: 1

Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites
Rajan Singh, Anshul Anand, Baishakhi Mahapatra, et al.
Molecular Immunology (2023) Vol. 163, pp. 136-146
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top